ABSTRACT
INTRODUCTION-(1)(2)
Lovastatin, a specific and potent competitive inhibitor of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) is a powerful serum cholesterol-lowering drug in humans and other species. It is formerly called as mevinolin; monacolin K, and mevacor® and it is a fungal secondary metabolite which inhibits HMG-CoA reductase (E.C 1.1.1.34), the first committed enzyme of cholesterol biosynthesis. The endogenous synthesis of cholesterol is carried out by the mevalonate pathway, in which the rate limiting reaction is the conversion of (S) HMG-CoA to (R) mevalonate, catalyzed by HMG-CoA reductase. The history of statin began in 1987 when the lovastatin received Food and Drug Administration (FDA) approval in the USA (Manzoni and Rollini 2002). Lovastatin have revolutionized the treatment of hypercholesterolemia and it is proven that lovastatin is also therapeutically and preventatively effective in the treatment of major kind of diseases like atherosclerosis, sepsis, peripheral arterial disease, peripheral vascular disease, cerebro vascular disease, ischemic disease, and bone fracture. Structure Lovastatin is
The empirical formula of lovastatin is C24H36O5 and molecular weight is 404.55. Structure of Lovastatin is shown in Fig. 1 . 
Instruments Used:-
A double beam UV-VIS spectrophotometer (UV-1800, Shimadzu) with spectra manager software UV Probe 2.21 was used. All weights were taken on electronic balance (Model Shimadzu AUX 120).
Method:-Preparation of Standard Solution
Stock solution of 100 μg /ml of lovastatin was prepared by transferring an accurately weighed 10 mg of Lovastatin into 100 ml volumetric flask and diluted up to the mark with water.
Selection of Wavelength Range-
The standard solution of 10 μg /ml was scanned between 400 nm to 200 nm in UV spectrophotometer against water as a blank after baseline correction. The wavelength range was selected around wavelength maxima (248nm).
AREA UNDER CURVE-(3)
When there is no sharp peak or when broad spectra are obtained, The AUC (area under curve) method is usually applicable. This method consists of calculation of integrated value of absorbance with respect to the wavelength between the two selected wavelengths λ 1 and λ 2 . Area calculation processing item calculates the area bound by the curve and the horizontal axis. The horizontal axis is selected by entering the wavelength range over which area has to be calculated. This wavelength range is selected on the basis of repeated observation so as to get the linearity between area under curve and concentration. The above mentioned spectrums were used to calculate AUC. Thus, the calibration curve can be constructed by plotting concentration versus AUC. 
PREPARATION OF CALIBRATION CURVE
Working solutions were prepared from standard stock solution by further dilution with water to obtain the concentration of 5,10,15,20 and 25μg /ml respectively. These solutions were scanned from 400 to 200nm and area under curve was integrated in the range of 238-258 nm. The calibration curve was plotted between areas under curve against concentration. 
ASSAY OF TABLET
Twenty tablets (Lovastatin) containing 10 mg of Lovastatin weighed, average weight calculated and triturated to fine powder and then weight equivalent 10 mg of Lovastatin transferred into 100ml of volumetric flask and dissolved in water and diluted up to the mark with water to get a solution containing of 100 μg /ml from the 2.5 ml was transferred to 25 ml volumetric flask and diluted up to the mark with water to get lovastatin solution containing 10 μg /ml of Lovastatin. 
VALIDATION:-(4)
The developed method was validated as per ICH guidelines.
Linearity
The linearity was determined by using working standard solution between 5-25 μg/ml. The spectrums of thissolution were recorded and integrated at wavelength range 248 nm. Calibration curve of Conc. Vs AUC was plotted after suitable calculation and simple linear regression was performed.
Precision
The precision of the method was checked by repeatedly injecting 5-15 μg/ml. Absorbance of each of these solutions was measured at the 248 nm. Percent relative standard deviation (RSD) was calculated.
Accuracy
The accuracy for the analytical procedure was determined at 80%, 100% and 120% level of standard solution. Absorbance was measured at the range 248nm and result was expressed in term % recoveries. Three determinations at each level were performed and %RSD was calculated.
Sensitivity
The International Conference on Harmonization (ICH) [16] guidelines on determination of limit of detection (LOD) and limit of quantitation (LOQ) define LOD as 3 s/δ while LOQ as 10 s/δ, where s is the standard deviation of replicate determination values under the same conditions as for the sample analysis in the absence of the analytes and δ is the sensitivity, the slope of the calibration curve.
RESULT AND DISCUSSION
The calibration curve of Lovastatin was performed and graph plotted concentration versus area under curve. 
ANALYSIS OF PURE DRUG
The standard solution of 10µg/ml was scanned between 400-200nm in UV spectrophotometer against methanol as a blank after baseline correction. The area Under Curve of Solution was measured. Table No. 3.
Statistical Evaluation of Pure Drug :-Statistical Evaluation of Pure Drug is shown in

ANALYSIS OF MARKETED FORMULATION
Twenty Tablets (lostatin) containing 10mg of lovastatin weighed, average weight calculated and Triturated to fine powder, then weighed equivalent to 10mg of lovastatin and transferred to the 100ml of volumetric flask and dissolved into methanol. Diluted up to the mark with methanol to get solution containing 100µg/ml. From this, 2.5ml was transferred to the 25ml volumetric flask and diluted up to the mark with methanol to get Lovastatin solution containing 10µg/ml of Lovastatin and results were obtained. Table 5 shows statistical evaluation of marketed formulation.
Statistical Evaluation of Marketed Formulation
VALIDATION
Linearity
Calibration curve of area under curve versus concentration was plotted after suitable calculation and simple linear regression was performed and results were shown in Table 1 and Fig.2 .The regression equation obtained is y=0.2054x-0.1624. and R 2 =0.9949.
Precision
Percent relative standard deviation (RSD) was calculated and results are shown in Table 7 . The %RSD for the Intraday and Interday was found to be 3.17 and 3.30 respectively.
Accuracy
The % recovery was obtained between the 98.73 to108 as shown in table no.8. The proposed method was found to be precise, % RSD value for interday and intraday precision were satisfactory. The drug has good recoveries (99.8%). Hence, it can be said that this method is accurate.
The result of analysis of formulation by developed method was consistent with labeled claim, highly reproducible and reliable.The method can be used for routine analysis of Lovastatin. The validation parameters are summarized in table no.9.
CONCLUSION
No any spectrophotometric methods have been described for AUC estimation of Lovastatin. Therefore, simple, fast and reliable area under curve spectrophotometric method was developed for routine analysis of Lovastatin. The developed method can be concluded as accurate, sensitive and precise and be easily applied to the pharmaceutical formulation.
